Astraea
Astraea is a Y Combinator-backed (Spring 2026) clinical trial automation platform that gives pharmaceutical sponsors, biotechs, and CROs an AI operating system for clinical development. Founded by Joshua Wang and Sanmay Sarada, the platform orchestrates specialized AI agents across the full biometrics lifecycle - standards mapping, data normalization, CDISC mapping, SDTM and ADaM dataset generation, TFLs/TLFs, SAP, eCRFs, Define-XML, QC, and submission documents - turning a protocol and raw study data into FDA-submission-ready output. Astraea is positioned as sponsor-run software rather than a CRO: it runs inside the customer's own secure environment so clinical data never reaches Astraea's servers, with 21 CFR Part 11 compliance and audit-ready, standards-native traceability. The company reports serving 10+ global pharma and biotech sponsors with 30-50% faster reporting cycles.
Astraea is profiled on the APIs.io network. Tagged areas include Company, Clinical Trials, Healthcare, Life Sciences, and Artificial Intelligence.
Astraea’s developer surface includes support and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 1
The organization behind the API